FDA warned Beeyoutiful.com that website claims made 26 supplement products unapproved drugs.
What happened
FDA reviewed www.beeyoutiful.com in April and May 2021 and found product pages and linked articles claiming that supplements such as Vitex w/ Dong Quai, Berry Well, and Colostrum Transfer Factor treat or prevent diseases including flu, cancer, urinary tract infections, and other conditions. FDA said these claims make the products drugs, and because they are not generally recognized as safe and effective for those uses and lack FDA approval, they are "new drugs." FDA also said some products are misbranded—illegal because their labeling lacks adequate directions for use—for diseases that require a licensed practitioner.
What FDA found
The website claims show the products are intended to cure, mitigate, treat, or prevent disease, so FDA considers them drugs.
FD&C Act section 201(g)(1)(B), 21 U.S.C. 321(g)(1)(B)The products are not generally recognized as safe and effective for the claimed uses and lack FDA approval, so they are "new drugs."
FD&C Act sections 201(p), 301(d), and 505(a), 21 U.S.C. 321(p), 331(d), 355(a)Some products are misbranded because they do not bear adequate directions for their intended use.
FD&C Act section 502(f)(1), 21 U.S.C. 352(f)(1); 21 CFR 201.5The products are intended for diseases that cannot be safely self-diagnosed or treated without a licensed practitioner, so adequate directions cannot be written for a layperson.
FD&C Act section 502(f)(1), 21 U.S.C. 352(f)(1)Introducing these misbranded drugs into interstate commerce violates the Act.
FD&C Act section 301(a), 21 U.S.C. 331(a)
What FDA wants
FDA tells the company it is responsible for investigating and determining the causes of the violations and for preventing their recurrence or other violations. The provided excerpt does not state a response deadline.
Who should pay attention
- dietary supplement brands that make disease-treatment claims
- online retailers and affiliate marketers of supplements
- companies whose product pages link to health articles and testimonials
This is a summary. Read the original letter on fda.gov.